Osteoarthritis Trial, Recruiting NCT07580222 Sponsor: VA Office of Research and Development Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07580222
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are veterans or non-veterans (both are welcome)
  • People of any gender (male or female)
  • People who have been diagnosed with early-stage knee osteoarthritis
  • People who previously took part in a specific study called "Precision Assessment of Platelet Rich Plasma for Joint Preservation" (ClinicalTrials.gov ID: NCT03460236)
  • People who are able and willing to give written consent to take part in this follow-up study

Who may not be able to join:

  • People who have painful osteoarthritis in other lower body joints (such as the hip or ankle), not just the knee
  • People who have had a joint replacement
  • People who have a rheumatic disease (a condition affecting the joints, muscles, or connective tissue)
  • People with a body mass index (a measure of body weight relative to height) above 35 kg/m²
  • People with a serious ongoing health condition classified as ASA level 3 or higher (a medical rating system used by anaesthesiologists to describe overall health — confirm with trial site if unsure how this applies)
  • People who are pregnant or planning to become pregnant during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jade He, PhD, VA Palo Alto Health Care System, Palo Alto, CA

Phone: (650) 493-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
30 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Knee flexion angle

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov